Screening and diagnostic value of the detection of microRNAs in stool of patients with pancreatic ductal adenocarcinoma

Jian-yu YANG,Yong-wei SUN,Rong HUA

DOI: https://doi.org/10.13709/j.cnki.1007-1954.2014.05.011

2014-01-01

Abstract:Objective To detect the miRNAs in cancer tissues, matched adjacent benign pancreatic tissues and stool with patients of pancreatic ductal adenocarcinoma and to evaluate the diagnostic value of stool miRNAs.Methods MiRNAs were extracted from clinical specimens who included cancer and matched adjacent benign pancreatic tissues of 30 cases of PDAC, the 10 cases of CP and 15 cases of healthy volunteers. Relative expression of a panel of 5 dysregulated miRNAs(miR-21, miR-155, miR-196 a, miR-216 and miR-217) was analyzed with QRT-PCR. Receiver operating characteristic curve(ROC) and AUC(area under the curve) analysis was performed to assess the diagnostic value of stool miRNAs in PDAC patients. Results The expression of 5 miRNAs in all samples was detected. The study showed that our methods of extracting and detecting miRNAs from stool specimens had high reproducibility. Compared with matched adjacent benign pancreatic tissues, the expression of miR-21, miR-155 as well as miR-196 a was significantly higher and the expression of miR-216 and miR-217 was significantly lower in primary tumor tissues of PDAC patients(P0.01). PDAC patients had a significantly higher stool miR-21 and miR-155 and lower miR-216 level compared to normal controls(P0.05). The same results were obtained in the expression levels of stool miR-21, miR-155 and miR-216 between PDAC and CP patients(P=0.0337, P=0.0388 and P=0.0117, respectively). Receiver operating characteristic(ROC) analysis using stool miRNAs expression indicated that combination of miR-21 and miR-155 had best sensitivity of 93.33%while the combination of miR-21, miR-155 and miR-216 would be best for detecting and screening PDAC with area under the curve(AUC) of 0.8667(95%CI: 0.7722-0.9612) and a better balance of sensitivity and specificity(83.33 % and 83.33%). Conclusion Our data indicate that miRNAs can be extracted and detected from pancreatic juice and stool efficiently and reproducibly. MiR-21, miR-155 and miR-216 in stool have the potential of becoming biomarkers for screening PDAC.